
Opinion|Videos|August 1, 2024
The Impact of Fusion-Guided Biopsy on Focal Therapy in Prostate Cancer
Author(s)Kyrollis Attalla, MD
An expert on prostate cancer discusses how fusion-guided biopsy can help determine patient eligibility for focal therapy.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- How can fusion-guided biopsy help determine patient eligibility for focal therapy?
- What advantages do 3D MRI/US fusion biopsy systems offer over conventional biopsy methods in terms of focal therapy imaging and planning?
- How may better accuracy and precision in lesion identification help improve treatment outcomes in patients receiving focal therapy?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Kari Tikkinen, MD, PhD, discusses POISE-3 findings on tranexamic acid in urologic surgery
4
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
5












